Medindia

X

ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2008 Financial Results

Friday, February 13, 2009 General News J E 4
Advertisement
IRVINE, Calif., Feb. 12 ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will release fourth quarter and full-year 2008 financial results on February 19, 2009, and will host a conference call to discuss these results and provide a pipeline update at 5:00 p.m. Eastern Time.



To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 11605791. This conference call also will be webcast live and archived on ISTA's website until March 19, 2009.



About ISTA Pharmaceuticals

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.



Date: Thursday, February 19, 2009 Time: 5:00 p.m. Eastern Time Conference call access: Internet: www.istavision.com Domestic dial-in: 866-730-5766 International dial-in: 857-350-1590 Passcode: 52070700

SOURCE ISTA Pharmaceuticals, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Resurrection Health Care & Merit Sleep Centers Lau...
S
Guardian Highlights the Importance of Critical Ill...